Loading…
for educational and safety purposes
IGF-1 LR3 and PEG-MGF both come up in the same conversations. IGF-1 LR3: IGF-1 LR3 (Long[Arg3]IGF-I) is an engineered analog of insulin-like growth factor 1 built to slip past the binding proteins that normally hold IGF-1 in check, making it substantially more potent at driving cell growth [1][2]. PEG-MGF: PEG-MGF is a stability-engineered form of mechano growth factor (MGF), a splice variant of the IGF-1 gene that is switched on in muscle by mechanical loading and damage.
IGF-1 LR3 (Long[Arg3]IGF-I) is an engineered analog of insulin-like growth factor 1 built to slip past the binding proteins that normally hold IGF-1 in check, making it substantially more potent at driving cell growth [1][2]. It combines a single amino acid swap at position 3 (glutamate to arginine) with a 13-residue N-terminal extension, and together these changes sharply lower its affinity for the IGF-binding proteins while preserving strong activation of the IGF-1 receptor [1]. The result is a highly active anabolic research peptide widely used in cell culture and studied for its amplified, less-restrained IGF signaling [1][2].
PEG-MGF is a stability-engineered form of mechano growth factor (MGF), a splice variant of the IGF-1 gene that is switched on in muscle by mechanical loading and damage. Its C-terminal peptide is proposed to act as an early trigger that activates satellite (muscle stem) cells for repair before systemic IGF-1 takes over, and attaching a polyethylene glycol group is intended to extend its very short circulating life. Whether the synthetic C-terminal MGF peptide has genuine biological activity is still scientifically disputed, with published studies on both sides, and PEG-MGF remains an unapproved research peptide.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
agonist (long-acting)
raises
inhibits
lowers (hypoglycemia risk)
PEGylation shields the peptide from rapid degradation
Delivers the same fragment as MGF but with longer exposure
Proposed activation and proliferation, same as MGF
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.
easiest to source: IGF-1 LR3 is currently listed by more trusted vendors (5), so it's the simpler one to get hold of. for effects and safety, read each full entry; this is educational, not medical advice.